Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Medtronic
Accenture
US Department of Justice
McKesson
Covington
Chinese Patent Office
Harvard Business School
US Army

Generated: April 19, 2018

DrugPatentWatch Database Preview

QUELICIN Drug Profile

« Back to Dashboard

Which patents cover Quelicin, and when can generic versions of Quelicin launch?

Quelicin is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in QUELICIN is succinylcholine chloride. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the succinylcholine chloride profile page.
Drug patent expirations by year for QUELICIN
Pharmacology for QUELICIN
Medical Subject Heading (MeSH) Categories for QUELICIN
Synonyms for QUELICIN
.Succinylcholin
2,2'-[(1,4-DIOXOBUTANE-1,4-DIYL)BIS(OXY)]BIS(N,N,N-TRIMETHYLETHANAMINIUM)
2,2''-[(1,4-dioxobutane-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)
2ha2
2ha6
306-40-1
4-04-00-01451 (Beilstein Handbook Reference)
541-19-5 (diiodide)
55-94-7 (dibromide)
71-27-2 (dichloride)
AB00375912-06
AC1L1K2T
AKOS022084126
Anectine
Anectine (TN)
AXOIZCJOOAYSMI-UHFFFAOYSA-
BDBM50061568
BRN 1805311
C07546
CCG-205157
Celocurine
CHEBI:45652
CHEMBL703
Choline, succinate (2:1) (ester)
Choline, succinate (ester)
Choline, succinyl-
D0Q7ZQ
DB00202
di2-(trimethylamino)ethyl butane-1,4-dioate
Diacetylcholine
Dicholine succinate
diester with choline
Ditilin
Ditiline
DTXSID7048455
Epitope ID:116045
Ethanaminium, 2,2'-((1,4-dioxo-1,4-butanediyl)bis(oxy))bis(N,N,N-trimethyl-
Ethanaminium, 2,2'-((1,4-dioxo-1,4-butanediyl)bis(oxy))bis(N,N,N-trimethyl)-
ETHANAMINIUM,2,2'-[(1,4-DIOXO-1,4-BUTANEDIYL)BIS(OXY)]BIS[N,N,N-TRIMETHYL-
GTPL4004
HMS2090P14
HSDB 3254
InChI=1/C14H30N2O4/c1-15(2,3)9-11-19-13(17)7-8-14(18)20-12-10-16(4,5)6/h7-12H2,1-6H3/q+2
J2R869A8YF
L000926
Listenon
Lopac-S-8251
Lopac0_001080
LS-53328
Lysthenon
MCULE-7641058357
MLS001183716
MolPort-002-964-486
Myorelaxin
NCGC00015971-01
NCGC00015971-02
NCGC00015971-03
NCGC00015971-04
NCGC00162336-01
SCHEMBL41537
SCK
Scoline (TN)
SMR000677912
ST45025975
ST50437287
STK177290
Succicuran
succinic acid dicholine diester
Succinic acid, diester with choline
Succinic acid, diester with choline chloride
Succinocholine
Succinoylcholine
Succinyl choline
Succinylbischoline
succinylcholine
Succinyldicholine
Sucostrin
Suxamethonium
suxamethonium chloride
trimethyl-[2-[4-oxo-4-(2-trimethylazaniumylethoxy)butanoyl]oxyethyl]azanium diio
trimethyl-[2-[4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl]oxyethyl]azanium
trimethyl[2-({4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl}oxy)ethyl]azanium
UNII-J2R869A8YF
ZINC1530820

US Patents and Regulatory Information for QUELICIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira QUELICIN succinylcholine chloride INJECTABLE;INJECTION 008845-006 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira QUELICIN PRESERVATIVE FREE succinylcholine chloride INJECTABLE;INJECTION 008845-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira QUELICIN PRESERVATIVE FREE succinylcholine chloride INJECTABLE;INJECTION 008845-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira QUELICIN PRESERVATIVE FREE succinylcholine chloride INJECTABLE;INJECTION 008845-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Chinese Patent Office
Farmers Insurance
McKinsey
Chubb
Deloitte
QuintilesIMS
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.